Examples of using Nitisinone in English and their translations into Swedish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
-
Political
Ml contains 4 mg nitisinone.
Nitisinone has shown embryo-foetal toxicity in the mouse
Each ml contains 4 mg nitisinone.
It is unknown whether nitisinone is excreted in human breast milk.
Orfadin 2 mg hard capsules Nitisinone.
By its mode of action, nitisinone increases tyrosine levels in all nitisinone treated patients.
Each capsule contains 2 mg nitisinone.
The active substance in Orfadin, nitisinone, blocks an enzyme that converts tyrosine into harmful substances.
The active ingredient of Orfadin is nitisinone.
Treatment with nitisinone leads to higher levels of tyrosine in the blood which can cause eye related symptoms.
Orfadin contains the active substance nitisinone.
A patient displaying visual disorders during treatment with nitisinone should without delay be examined by an ophthalmologist.
Each capsule contains 10 mg nitisinone.
Nitisinone treatment should be initiated
10 mg nitisinone.
Nitisinone, the active substance in Orfadin,
What Orfadin contains The active substance is nitisinone.
Therefore, it is recommended that if nitisinone treatment is initiated with food,
Orfadin is a medicine that contains the active substance nitisinone.
It is recommended that if nitisinone treatment is initiated with food, this should be maintained on a routine basis,
Animal studies have shown adverse postnatal effects via exposure of nitisinone in milk.
Tyrosinemia type 1 can be treated with a specific medication called nitisinone, a special diet including protein replacements, and liver transplantation.
Orfadin 2 mg hard capsules Orfadin 5 mg hard capsules Orfadin 10 mg hard capsules nitisinone.
Therefore, mothers receiving nitisinone must not breast-feed,
elimination studies have not been performed with nitisinone.
Accidental ingestion of nitisinone by individuals eating normal diets not restricted in tyrosine
It is recommended that a slit-lamp examination of the eyes is performed before initiation of nitisinone treatment.
Nitisinone is metabolised in vitro by CYP 3A4 and dose-adjustment may therefore be needed when nitisinone is co-administered with inhibitors
Orfadin 2 mg hard capsules Orfadin 5 mg hard capsules Orfadin 10 mg hard capsules Orfadin 20 mg hard capsules nitisinone.
By inhibiting the normal catabolism of tyrosine in patients with HT-1, nitisinone prevents the accumulation of the toxic intermediates maleylacetoacetate and fumarylacetoacetate.